Parabilis Medicines, Inc. stock analysis: shares hit a two-year high, but no P/E or P/B means the model can’t issue a Buy/Hold/Sell call.
Chaudhry Kramat Ali
Chaudhry Kramat Ali
Chaudhry Kramat Ali is the pen name of three doctorate-level friends with expertise spanning finance, economics, and international law. Together, they bring over 30 years of multi-disciplinary experience in value investing — analysing businesses through the lens of fundamentals, institutional ownership data, and long-term capital allocation.
-
-
Analyst Upgrades & DowngradesFeatured
August Rotation Lifts Cyclicals as Analyst Upgrades Reinforce Institutional Risk Appetite
August sector rotation is lifting cyclicals as analyst upgrades and broader earnings confidence improve institutional market sentiment in 2026.
-
SemiconductorsUS Stocks
Marvell Technology’s Quality Score Is 81 – But Its Opportunity Score Is Just 12
Marvell Technology stock analysis: an 81/100 Quality score meets a 12/100 Opportunity score as earnings fall 80.4% against a 76x P/E.
-
Nu Holdings stock analysis: 43.7% revenue growth and 30% ROE, but missing balance-sheet data leaves the model without a Buy/Hold/Sell signal.
-
Capital MarketsFeaturedUS Stocks
Intercontinental Exchange Earns a Buy Signal on Balanced Fundamentals
Intercontinental Exchange Inc. stock analysis: balanced Quality, Growth, and Opportunity scores push the model to a Buy signal.
-
Archer Aviation Inc. stock analysis: pre-revenue eVTOL developer with strong liquidity but deep cash burn and no model signal yet.
-
SemiconductorsUS Stocks
Broadcom Is Near Its Two-Year High With Elite Margins – and a Valuation to Match
Broadcom Inc. stock analysis: elite 92/100 Quality and 85/100 Growth scores meet a stretched valuation near two-year highs.